TEK and breast cancer: Furthermore, the simultaneous activation of Tie2 and inhibition of Ang2 using an antibody capable of triggering Tie2 phosphorylation through clustering of Ang2 has normalized tumor vessels in orthotopic GBM, subcutaneous Lewis lung carcinoma, and spontaneous mammary cancer models70,71.